Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer

Clinical trial NCT07551050 · RECRUITING

Trial details

NCT number: NCT07551050
Sponsor: Fudan University
Status: RECRUITING
Study type: OBSERVATIONAL

TNBC - Triple-Negative Breast Cancer

Start date: 2026-05-15
Primary completion: 2029-04-15
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.